Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30317424

One year versus a shorter duration of adjuvant trastuzumab for HER2-positive early breast cancer: a systematic review and meta-analysis.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Breast Cancer Res Treat
Publication date
2019 Jan
First author
Inno A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Inno A
      type
      Author
    2. name
      Barni S
      type
      Author
    3. name
      Ghidini A
      type
      Author
    4. name
      Zaniboni A
      type
      Author
    5. name
      Petrelli F
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Inno A
      type
      Author
    2. name
      Barni S
      type
      Author
    3. name
      Ghidini A
      type
      Author
    4. name
      Zaniboni A
      type
      Author
    5. name
      Petrelli F
      type
      Author
    bibliography ids
    1. nci-bib-ed6142f65f90f8123c142af5
    book metadata
    content sha256
    71b59f02e6a92cb29d7c814b149705bfc84c05159aae6ed4d67b42d465ccd0b3
    document type
    citation
    dois
    1. 10.1007/s10549-018-5001-x
    electronic publication date
    display
    2018 Oct 13
    precision
    day
    year
    2018
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:30317424
    immutable id
    pubmed:30317424@71b59f02e6a92cb29d7c814b149705bfc84c05159aae6ed4d67b42d465ccd0b3
    journal
    abbreviation
    Breast Cancer Res Treat
    issn electronic
    1573-7217
    issn print
    0167-6806
    issue
    2
    name
    Breast cancer research and treatment
    nlm unique id
    8111104
    pages
    247-254
    volume
    173
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      30317424
      provenance
      batch id
      438b2803888025c6cf56
      provider
      NCBI PubMed ESummary
      record sha256
      dced9ed2fa09a0993126cb9b991add488d5c3673c050e381cdb58d4f40cda4db
      response sha256
      0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
      retrieved at
      2026-09-09T23:47:36.359220+00:00
      publication date
      display
      2019 Jan
      precision
      month
      year
      2019
      publication types
      1. Comparative Study
      2. Journal Article
      3. Meta-Analysis
      4. Systematic Review
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/30317424/
      title
      One year versus a shorter duration of adjuvant trastuzumab for HER2-positive early breast cancer: a systematic review and meta-analysis.

      Preserved source evidence · Not medical advice